Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease
Open Access
- 1 January 2008
- journal article
- Published by American Society of Hematology in Blood
- Vol. 111 (1) , 402-410
- https://doi.org/10.1182/blood-2007-04-081703
Abstract
Erythrocyte glutathione depletion has been linked to hemolysis and oxidative stress. Glutamine plays an additional antioxidant role through preservation of intracellular nicotinamide adenine dinucleotide phosphate (NADPH) levels, required for glutathione recycling. Decreased nitric oxide (NO) bioavailability, which occurs in the setting of increased hemolysis and oxidative stress, contributes to the pathogenesis of pulmonary hypertension (PH) in sickle cell disease (SCD). We hypothesized that altered glutathione and glutamine metabolism play a role in this process. Total glutathione (and its precursors) and glutamine were assayed in plasma and erythrocytes of 40 SCD patients and 9 healthy volunteers. Erythrocyte total glutathione and glutamine levels were significantly lower in SCD patients than in healthy volunteers. Glutamine depletion was independently associated with PH, defined as a tricuspid regurgitant jet velocity (TRV) of at least 2.5 m/s. The ratio of erythrocyte glutamine:glutamate correlated inversely to TRV (r = −0.62, P < .001), plasma arginase concentration (r = −0.45, P = .002), and plasma-free hemoglobin level (r = −0.41, P = .01), linking erythrocyte glutamine depletion to dysregulation of the arginine-NO pathway and increased hemolytic rate. Decreased erythrocyte glutathione and glutamine levels contribute to alterations in the erythrocyte redox environment, which may compromise erythrocyte integrity, contribute to hemolysis, and play a role in the pathogenesis of PH of SCD.Keywords
This publication has 104 references indexed in Scilit:
- Diastolic Dysfunction Is an Independent Risk Factor for Death in Patients With Sickle Cell DiseasePublished by Elsevier ,2007
- Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailabilityBlood, 2006
- Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypesBlood Reviews, 2006
- Protective effect of arginine on oxidative stress in transgenic sickle mouse modelsFree Radical Biology & Medicine, 2006
- In vivo rates of erythrocyte glutathione synthesis in adults with sickle cell diseaseAmerican Journal of Physiology-Endocrinology and Metabolism, 2006
- Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF‐β/BMP pathwayBritish Journal of Haematology, 2006
- Hemolysis‐Associated Pulmonary Hypertension in ThalassemiaAnnals of the New York Academy of Sciences, 2005
- Differential gene expression in pulmonary artery endothelial cells exposed to sickle cell plasmaPhysiological Genomics, 2005
- Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell DiseaseNew England Journal of Medicine, 2004
- Relationship between the nicotinamide adenine dinucleotide redox potential and the 2,3-diphosphoglycerate content in the erythrocyte in sickle cell diseaseBritish Journal of Haematology, 1989